IXICO PLC
LSE:IXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Canafarma Hemp Products Corp
CNSX:CNFA
|
CA |
|
M
|
Mitra Angkasa Sejahtera PT Tbk
IDX:BAUT
|
ID |
|
B
|
BGMC International Ltd
HKEX:1693
|
MY |
|
C
|
Chi Ho Development Holdings Ltd
HKEX:8423
|
HK |
|
ContraFect Corp
OTC:CFRXQ
|
US |
|
Iodm Ltd
ASX:IOD
|
AU |
|
P
|
Padmalaya Telefilms Ltd
BSE:532350
|
IN |
|
Torian Resources Ltd
ASX:TNR
|
AU |
|
E
|
eXeBlock Technology Corp
CNSX:XBLK.X
|
CA |
|
G
|
Guangzhou Devotion Thermal Technology Co Ltd
SZSE:300335
|
CN |
|
M
|
Matba Rofex SA
BCBA:MTR
|
AR |
|
Dynamic Group Holdings Ltd
ASX:DDB
|
AU |
|
C
|
China Ever Grand Financial Leasing Group Co Ltd
HKEX:379
|
HK |
|
Q
|
Quantong Holdings Ltd
HKEX:8316
|
HK |
|
K
|
Komo Plant Based Foods Inc
CNSX:YUM
|
CA |
|
Goldlok Holdings Guangdong Co Ltd
SZSE:002348
|
CN |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
|
IXICO PLC
LSE:IXI
|
7.2m GBP |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
975.8B USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
183.7B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
135.8B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
35.2B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
298.3B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.5B USD |
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
29.8B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD |
Loading...
|
Market Distribution
| Min | -195 650% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 4 630.7% |
Other Profitability Ratios
IXICO PLC
Glance View
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. The company provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for IXICO PLC is -39.1%, which is below its 3-year median of -26.5%.
Over the last 3 years, IXICO PLC’s Operating Margin has decreased from 10.5% to -39.1%. During this period, it reached a low of -39.1% on Sep 30, 2025 and a high of 10.5% on Sep 30, 2022.
